eIF2B (eukaryotic initiation factor 2B) is a multisubunit protein that is required for protein synthesis initiation and its regulation in all eukaryotic cells. Mutations in eIF2B have also recently been found to cause a fatal human disease called CACH (childhood ataxia with central nervous system hypomyelination) or VWM (vanishing white matter disease). This review provides a general background to translation initiation and mechanisms known to control eIF2B function, before describing molecular genetic and biochemical analysis of eIF2B structure and function, integrating work from studies of the yeast and mammalian eIF2B proteins.
The role of eIF2B in initiation eIF2 released from the ribosome is bound to GDP. GDP must be replaced by GTP to enable ternary complex formation. As eIF2 has a higher affinity for GDP [3] , eIF2B functions to promote guanine nucleotide exchange ( Figure 1 ). eIF2 · GTP formed is not stable unless Met-tRNA i Met joins to form the ternary complex [4] . This is one of the rate-limiting steps of translation initiation. Met-tRNA i Met is usually in abundance, making the eIF2B-catalysed step rate-limiting. Compared with other GEFs (guanine nucleotide-exchange factors), eIF2B is remarkably complex, containing five subunits. One reason for this complexity is probably the fact that eIF2B is regulated by diverse signals.
Diverse stresses regulate eIF2B via a common mechanism
Further evidence that eIF2B is a key limiting factor for translation comes from the fact that it is a target of translational control by different mechanisms, particularly in response to cellular stress ( Figure 1 ). One well-studied and evolutionarily conserved mechanism is via phosphorylation of the α subunit of eIF2. Several different protein kinases are activated in response to diverse stresses. Once active, all phosphorylate an evolutionarily conserved serine residue (Ser 51 ) in the N-terminal domain of the α subunit. Once phosphorylated, eIF2 has a higher affinity for eIF2B [5] , but instead of promoting nucleotide exchange, the increased affinity reduces the nucleotide-exchange function.
The kinases that regulate eIF2B in this way include the HRI (haem-regulated inhibitor of translation) that primarily functions in reticulocytes to balance globin synthesis with haem availability. Haem binds to and inactivates HRI, but when haem availability is limited, it is released, activating HRI. Cartoon representing the five subunits of eIF2B and its guanine nucleotide-exchange reaction with eIF2 to promote ternary complex formation. eIF2B is surrounded by diverse regulatory inputs that are discussed in the text. Blocked arrows inhibit eIF2B activity.
HRI is also controlled by nitric oxide and heat shock. Recently, two homologues of HRI have been described in the yeast Schizosaccharomyces pombe, where they respond to oxidative stress [6] . PKR (protein kinase R) transcription is interferon-induced and the protein is activated by binding double-stranded RNAs, as part of the cellular antiviral response. Many viruses have evolved diverse mechanisms to counteract PKR activation and enable productive infection of cells. These are not described here (but see [7] , for a recent review). High-level activation of HRI and PKR in cells can dramatically inhibit almost all protein synthesis in the affected cells. In contrast, two other eIF2 kinases appear to moderate protein synthesis more subtly, to enable activation of specific stress-responsive genes that are controlled at the level of translation. The PERK [PKR-like ER (endoplasmic reticulum) kinase], also called the PEK (pancreatic eIF2 kinase) [8, 9] , is an ER resident protein with an ER luminal domain that responds to the stress of unfolded proteins in the ER, a transmembrane domain and a cytoplasmic eIF2 kinase domain. In response to the accumulation of unfolded proteins in the ER, PERK activation should limit translation of ER-destined proteins, while signals sent to the nucleus enhance the synthesis of ER chaperones, e.g. Bip. Finally, yeast Saccharomyces cerevisiae Gcn2p (general control non-derepressible 2) and its Drosophila and mammalian counterparts dGCN2 and mGCN2 respectively [10] [11] [12] respond primarily to limitation of one or more amino acids. Studies have shown that deacylated tRNAs bind to a domain of Gcn2p that resembles histidyl tRNA synthetase [13] . Residues in this domain conserved with real tRNA synthetase enzymes are necessary for Gcn2p activation [14] . Thus many stress signals can regulate eIF2B activity by signalling via eIF2 kinases and phosphorylating eIF2α at Ser 51 . Down-regulation of eIF2B activity by these kinases enables two responses: a general reduction in the translation of most mRNAs in cells and a simultaneous enhancement of translation of stress-responsive mRNAs. This was first described for yeast GCN4, where four short uORFs (upstream open reading frames) in the 5 -leader region restrict the flow of translating ribosomes to the GCN4 ORF under nutrientcomplete conditions. Ribosomes translate uORF 1 and then continue along the mRNA and translate one of the remaining uORFs and dissociate before reaching the GCN4 ORF. However, upon amino acid starvation, Gcn2p activation limits ternary complex levels, enabling ribosomes that have translated uORF1 to bypass the inhibitory uORF2-uORF4 and to translate GCN4 instead. This elevates Gcn4p levels by approx. 10-fold. Gcn4p activates transcription of many genes including 73-amino-acid biosynthetic enzymes that enable yeast cells to adapt to the starvation conditions imposed. See recent reviews for further details of this regulatory mechanism [15] [16] [17] . Recently, it has been shown that mammalian ATF4 (activating transcription factor 4) translation is regulated by a similar mechanism following PERK/PEK or mGCN2 activation [18, 19] .
Direct regulation of eIF2B
Other ways of regulating eIF2B have been described. First, direct phosphorylation of eIF2B has been described for mammalian eIF2B. Four protein kinases have been found to phosphorylate eIF2B: CK1 and CK2, DYRK (dual-specificity tyrosine phosphorylated and regulated kinase) and GSK3 (glycogen synthase kinase 3) [20, 21] . Of these GSK3 is thought to play the greatest role in regulation of eIF2B activity. DYRK phosphorylates rat eIF2Bε at Ser 539 and acts as a priming kinase that allows phosphorylation at Ser 535 by GSK3 [21] . GSK3 activity is regulated by insulin signalling such that in the presence of insulin, GSK3 activity is inhibited, eIF2B is dephosphorylated and the protein is more active. Phosphorylation of eIF2B by GSK3 has a role in apoptosis, as cells overexpressing eIF2B kinase substrate mutants are protected from apoptosis induced by overexpresion of GSK-3β [22] .
Yeast eIF2B activity can also be inhibited by fusel alcohols. Fusel alcohols such as butanol and 3-methylbutan-1-ol are amino acid breakdown products. They only accumulate when amino acids are used as nitrogen source, so are thought to signal nitrogen scarcity. In addition to inducing morphological changes to yeast cells, fusel alcohols cause a rapid inhibition of translation initiation and activation of GCN4 expression independent of Gcn2p. As certain missense mutations in eIF2B alter the sensitivity of yeast cells to these compounds, translational regulation is thought to act by inhibiting eIF2B function [23] . How fusel alcohols inhibit eIF2B is not yet understood.
eIF2B structure and response to eIF2(αP)
eIF2B is a complex of five non-identical subunits α-ε that are well conserved from yeast to human (see Table 1 , Figure 2 ). How eIF2B senses and responds to eIF2α phosphorylation at Ser 51 has been studied extensively in yeast. Initially genetic studies found that eIF2Bα (Gcn3p) was dispensable for cell viability but required for GCN4 translation. Therefore this subunit is not required for eIF2B GEF activity, but necessary for regulation by eIF2α phosphorylation. Later biochemical measurement of eIF2B activity confirmed these observations and showed that the four-subunit form missing eIF2Bα performed the GEF function well, but failed to distinguish between eIF2(αP) · GDP and eIF2 · GDP [24, 25] . Sequence analysis of eIF2Bα showed that it was similar over its entire length to two other subunits, eIF2Bβ and the C-terminal half of eIF2Bδ, suggesting that these two subunits may act with eIF2Bα to regulate eIF2B. Evidence to support this came from two experimental approaches. First, genetic screens identified multiple single missense mutations in all these three eIF2B subunits with the same phenotype. All were able to reduce the sensitivity of eIF2B to eIF2(αP) without altering eIF2B GEF activity (Figure 2 ) [26, 27] . Secondly, it was found that by co-overexpressing the α, β and δ subunits in cells they could reduce the inhibition of protein synthesis observed by eIF2(αP) hyperphosphorylation. This was explained by concluding that all three overexpressed subunits form a subcomplex that has a high affinity for phosphorylated eIF2 [25, 28] . Therefore the three homologous subunits act together to form a single regulatory domain that can sense the phosphorylation status of eIF2α. Some of the regulatory mutations act to reduce the affinity of the eIF2(αP)-eIF2B interaction [29] . Why three separate subunits are all required to sense a single phosphate addition to Ser 51 and how these three subunits contact eIF2α remains unclear.
Recent structural studies with human eIF2α comparing the wild-type protein with a mutant S51D (Ser 51 → Asp) phosphorylation mimic protein have revealed that there are changes in eIF2α structure that extend away from the Ser 51 residue [30] . In addition, yeast eIF2α mutants indicate that there is an extensive surface of eIF2α that is required for both eIF2 kinase recognition of the unphosphorylated form and eIF2Bαβδ recognition of the phosphorylated form [31] . Can the results of yeast experiments be applied to mammalian eIF2B? So far an equivalent eIF2Bαβδ subcomplex has not been identified in studies with mammalian eIF2B subunits; however, recombinant rat eIF2B complexes containing mutations equivalent to some eIF2Bδ missense mutations, or missing eIF2Bα entirely, were found to be resistant to eIF2(αP) in the same way as the yeast proteins [32] . This suggests that the regulatory interface between eIF2(αP) and eIF2B is likely to have been conserved through evolution.
Catalysis of guanine nucleotide exchange
Despite the fact that GTP-binding proteins, such as eIF2γ , have a well conserved nucleotide-binding domain and conserved tertiary structures, their GEFs are diverse in primary and tertiary structure and mechanism of action [33] . With five subunits, eIF2B is the most complicated of all described so far. Mutations that reduce eIF2B catalytic function in yeast have been described in all five subunits. Even though deletion of GCN3 (eIF2Bα) does not reduce GEF activity, there are many gcn3 mutations (called gcn3 constitutive or gcn3 c ) that reduce eIF2B function [24] . Similarly, non-lethal mutations in the other four eIF2B subunits also impair eIF2B activity (see Figure 2) . Thus genetics studies alone could not identify which subunit is the principal catalytic subunit. Complementary biochemical analysis revealed that eIF2Bε alone or in complexes possesses GEF activity. Yeast, Drosophila and rat eIF2Bε have been directly assayed. Assays comparing the activity of ε alone with five-subunit native complexes for yeast and mammalian eIF2B found that complex formation stimulates GEF activity 10-40-fold [25, 34, 35] . The enhanced activity correlates in part with increased affinity for eIF2 [25, 36] .
It was found that the C-terminal residues (518-712) contained a minimal functional unit that could interact with eIF2 and displace GDP [37] . Bipartite motifs rich in aromatic and acidic residues were found to be conserved at the C-termini of eIF2Bε (residues 654-712) and eIF5. This region has been termed the AA box motif; the W2 motif (as two of the most conserved residues are tryptophans), or the eIF5C motif. Both eIF2B and eIF5 interact with eIF2 at different phases of its G-protein cycle. Multiple alanine substitution mutations within the conserved residues of eIF2Bε and eIF5 significantly reduced the affinity of both factors for eIF2. The binding site was localized to N-terminal lysine-rich motifs within the eIF2β subunit, as mutation of these lysine blocks disrupted interactions with both eIF2B and eIF5, as well as eIF3 [38] . eIF2Bε residues 581-712 were able to interact with eIF2, confirming that this region alone is sufficient for interaction with eIF2. Additional residues from 518-580 are required for GEF function. This second region is also well conserved in eIF2Bε sequences suggesting an important function, and mutation of three conserved residues has been shown to impair or eliminate activity. The term 'catalytic centre' has been coined to describe its function. A random mutagenesis screen identified residues Thr 552 and Ser 576 as important for eIF2B function in vivo. The T552A and S576N alleles both impair general protein synthesis and elevate GCN4 expression in vivo as well as impairing GEF activity of the isolated eIF2Bε subunit [36] . Remarkably, a directed alanine substitution series targeting other well-conserved residues found that most changes examined had no obvious effect on eIF2B activity. However, Glu 569 was found to be important as mutation E569A was lethal in vivo, and highly sensitive genetic assays indicate that the mutated protein has no residual activity (Figure 2 ) [39] . An atomic resolution structure for the catalytic domain of eIF2Bε (residues 524-702) revealed that it is formed from four stacked pairs of α-helices similar to HEAT repeats (named after Huntingtin, elongation factor 3, the 65 kDa alpha regulatory subunit of protein phosphatase 2A and the yeast phosphoinositide 3-kinase TOR1) [39] . The conserved residues of the catalytic centre are arranged at one end with the residues identified by mutagenesis, Glu 569 , Thr 552 and Ser 576 , clustered at the surface. At the C-terminal end, the conserved residues of the AA motifs are largely important for structural integrity of the domain, but the surface is extensively charged (acidic) and this is probably important for interaction with the lysine blocks of eIF2β.
Overall these findings suggest that eIF2B interacts with eIF2 via an interaction with eIF2β and then separate residues at the catalytic centre are important to mediate guanine nucleotide exchange. By analogy with other nucleotide exchange factors, it seems reasonable to suggest that there is a direct interaction between the catalytic centre and eIF2γ , as it is eIF2γ , not eIF2β, that is primarily responsible for binding GDP/GTP. But as no direct interaction between eIF2B and eIF2γ has yet been reported, it remains possible that eIF2B functions in a different way from that of other exchange factors.
There remain several unresolved questions. What are the roles of the N-terminal 500 residues of eIF2Bε and eIF2Bγ ? These subunits interact with each other [40] and at least for the yeast pair, eIF2Bγ enhances the activity of eIF2Bε leading to the idea that these subunits form the catalytic subcomplex [25] . These two subunits share sequence similarity with each other and with a family of bifunctional nucleotide-binding enzymes such as ADP-glucose pyrophosphorylase, suggesting that nucleotide binding here may be important for eIF2B activity. GTP would be the obvious candidate, but UV cross-linking experiments indicate that GTP preferentially binds eIF2Bβ, despite there being no obvious nucleotidebinding sequence motif [41] . Deletion of residues 1-158 from rat eIF2Bε, dramatically reduced GEF activity and reduced association with eIF2Bα and eIF2Bγ implying that the region is critical for complex stability and activity [42] . However, mutations in yeast eIF2Bε at Asn 249 and Phe 250 dramatically impair the activity of the yeast holoenzyme, while not reducing complex formation or eIF2 interaction. Therefore there appears to be extensive cross-talk between different domains of eIF2B required both for its GEF activity and regulation by phosphorylated eIF2.
eIF2B and human disease
In December 2001, a paper appeared linking inherited mutations in eIF2B with a human brain disease called VWM (leukoencephalopathy with vanishing white matter, or vanishing white matter disease) or CACH (childhood ataxia with central nervous system hypomyelination) [43] . Other reports quickly followed and it is now clear that the disease is recessive and can be caused by missense mutations in any one of the five eIF2B subunits (Figure 2 ) [44, 45] . Mutations in both copies of one of the five genes must be inherited. The disease is chronic, progressive and fatal but has a wide clinical spectrum with onset varying from severe neonatal forms diagnosed within the first few months of life, to milder cases not apparent until adulthood. Often symptoms become apparent after a head trauma or following stress, e.g. a viral infection -conditions that can down-regulate eIF2B function [45] . Yeast [46] , human cell culture [40] and patient-derived, transformed lymphocyte models [47] for the disease have been developed, and all these model systems suggest that eIF2B activity is reduced in affected patients, with the degree of reduction showing some correlation with disease severity. As eIF2B is ubiquitously expressed, it was a surprise that eIF2B mutations would cause a tissue-specific disease. Several other leukoencephalopathies are caused by mutations in glial cell-specific proteins [48] . However, it is now clear that CACH/VWM patients often have other organ deficiencies, especially patients with severe, early onset forms. The principal cells affected are glial cells, astrocytes and oligodendrocytes. A recent report indicates that eIF2B activity may be especially critical for astrocyte differentiation [49] , but the molecular basis for how mutation causes disease
is not yet known. Perhaps the expression levels of the eIF2B subunits is especially low in glial cells, or is a glial cellspecific mRNA aberrantly translated? Further work will undoubtedly shed light on the role of eIF2B in this devastating disease.
Conclusions
eIF2B is a critical initiation factor whose activity is highly controlled in many different cell systems in response to a variety of cell stresses. Cells have developed molecular mechanisms to use eIF2B regulation to develop gene-specific translational controls (e.g. GCN4 and ATF4). Despite its complex structure, it has been possible to dissect functional domains within eIF2B. Challenges for the future will include a more detailed analysis of the structure-function relationships between eIF2B domains and eIF2, and uncovering the mechanism of action of novel stress pathways, such as fusel alcohols in yeast, and hopefully understanding of why defects in eIF2B cause a fatal human disease may help to identify a treatment.
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